Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges
Ampullary carcinomas (ACs) represent a rare entity, accounting for approximately 0.2% of all gastrointestinal solid tumors and 20% of all periampullary cancers (PACs). Unfortunately, few data are available regarding the optimal therapeutic strategy for ACs due to their rarity, and physicians frequen...
Main Authors: | Alessandro Rizzo, Vincenzo Dadduzio, Lucia Lombardi, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/28/5/293 |
Similar Items
-
Acute Pancreatitis Following Endoscopic Ampullary Biopsies without Attempted Cannulation of the Ampulla of Vater
by: Spyridon Michopoulos, et al.
Published: (2016-11-01) -
Endoscopic versus surgical treatment of ampullary adenomas: a systematic review and meta-analysis
by: Ernesto Quaresma Mendonça, et al.
Published: (2016-01-01) -
Predictors of Recurrence After Pancreaticoduodenectomy in Ampullary Cancer: Comparison Between Non-, Early and Late Recurrence
by: Hui-Ping Hsu, et al.
Published: (2007-01-01) -
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results
by: Makoto Ueno, et al.
Published: (2020-11-01) -
Bile ductal mucosal dysplasia is a possible risk factor for adenocarcinoma in patients with adenomyomatous hyperplasia of the Vaterian system: a single-centre study from China
by: Weizheng Liu, et al.
Published: (2024-01-01)